Prognostic Factors for Liver Transplantation in Unresectable Hepatoblastoma

Abstract

Aim Hepatoblastoma is the most frequent hepatic tumor in children, and its initial presentation will affect treatment and prognosis. The aim of this study is to evaluate long-term results of liver transplantation in children with unresectable hepatoblastoma.

Patients and Methods This is a retrospective review of patients with hepatoblastoma who underwent liver transplantation, analyzing risk factors, tumor presentation, treatment, and long-term survival to identify prognostic factors.

Results Thirty-one patients underwent liver transplantation in the context of unresectable hepatoblastoma, mainly males (67%) and with risk factors such as prematurity (12.9%), maternal smoking (6.5%), and familial adenomatous polyposis (3.2%). Most frequent presentation was multifocal PRETEXT III (51.6%) and PRETEXT IV (45.2%), with metastasis at diagnosis in 12.9% and vascular involvement in 54.8%.

Twenty-one patients received a living-donor (67.7%) and 10 a cadaveric graft (32.2%), at 31.7 months of age (5–125). Most transplants were primary, and only two were performed as rescue therapy after an attempt of surgical resection of the tumor.

Overall survival 1 and 5 years after transplantation were 93.3% ± 4.6% and 86.4% ± 6.3%, respectively. We could not find any statistically significant differences between risk factors, tumor presentation, type of graft, or type of transplant.

Conclusion Liver transplantation has increased hepatoblastoma survival in unresectable tumors. Probably due to these good results, we have not been able to find significant prognostic factors in this cohort.

Keywords

hepatoblastoma - liver transplantation - children - prognostic factors

• References

• 1 López-Terrada D, Finegold MJ. Tumors of the liver. In: Suchy FJ. , ed. Liver Disease in children. 4th ed. Cambridge University Press; 2014: 728-729
• 2 Czauderna P, López-Terrada D, Hiyama E, Häberle B, Malogolowkin MH, Meyers RL. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 2014; 26 (01) 19-28
• 3 Fuchs J, Rydzynski J, Von Schweinitz D. , et al; Study Committee of the Cooperative Pediatric Liver Tumor Study Hb 94 for the German Society for Pediatric Oncology and Hematology. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002; 95 (01) 172-182
• 4 Aronson DC, Schnater JM, Staalman CR. , et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 2005; 23 (06) 1245-1252
• 5 Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2009; 53 (06) 1016-1022
• 6 Meyers RL, Haeberle B, Hiyama E. , et al. Children's Hepatic Tumor International Collaboration (CHIC): new hepatoblastoma international risk groups. Paper presented at the 45th Congress of the International Society of Paediatric Oncology (SIOP), Hong Kong, China, September 25-28, 2013
• 7 Czauderna P, Haeberle B, Hiyama E. , et al. The Children's Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 2016; 52: 92-101
• 8 Meyers RL, Maibach R, Hiyama E. , et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration. Lancet Oncol 2017; 18 (01) 122-131
• 9 Hiyama E. Current therapeutic strategies for childhood hepatic malignant tumors. Int J Clin Oncol 2013; 18 (06) 943-945
• 10 Umeda K, Okajima H, Kawaguchi K. , et al. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: a single-institute experience. Pediatr Transplant 2018; 22 (02) e13113
• 11 Otte JB, Pritchard J, Aronson DC. , et al; International Society of Pediatric Oncology (SIOP). Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004; 42 (01) 74-83
• 12 Trobaugh-Lotrario AD, Meyers RL, O'Neill AF, Feusner JH. Unresectable hepatoblastoma: current perspectives. Hepat Med 2017; 9: 1-6
• 13 Shi Y, Commander SJ, Masand PM, Heczey A, Goss JA, Vasudevan SA. Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg 2017; 52 (06) 956-961
• 14 Browne M, Sher D, Grant D. , et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg 2008; 43 (11) 1973-1981
• 15 Trobaugh-Lotrario AD, Meyers RL, Tiao GM, Feusner JH. Pediatric liver transplantation for hepatoblastoma. Transl Gastroenterol Hepatol 2016; 1: 44
• 16 Czauderna P. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt. Front Biosci (Elite Ed) 2012; 4: 470-479
• 17 Pimpalwar AP, Sharif K, Ramani P. , et al. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery. J Pediatr Surg 2002; 37 (02) 240-245
• 18 Srinivasan P, McCall J, Pritchard J. , et al. Orthotopic liver transplantation for unresectable hepatoblastoma. Transplantation 2002; 74 (05) 652-655
• 19 Meyers RL, Tiao GM, Dunn SP, Langham Jr MR. Liver transplantation in the management of unresectable hepatoblastoma in children. Front Biosci (Elite Ed) 2012; 4: 1293-1302
• 20 Faraj W, Dar F, Marangoni G. , et al. Liver transplantation for hepatoblastoma. Liver Transpl 2008; 14 (11) 1614-1619
• 21 López-Terrada D, Alaggio R, de Dávila MT. , et al; Children's Oncology Group Liver Tumor Committee. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 2014; 27 (03) 472-491